HEPA Acquisition: a negative outcome, -7.7%

On October 9, 2026, Hepion Pharmaceuticals, Inc. reached its Acquisition. The result was a negative outcome, and the stock moved -7.7% in the window around the event. It had already run +100.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.